Skip to main content
. 2011 Sep;55(9):4050–4057. doi: 10.1128/AAC.00159-11

Table 6.

Zanamivir pharmacokinetics estimated from one- and two-compartment modelsa

Model kel (h−1) t1/2 (h) V1 (liter/kg) CL (liter/kg/h) V2 (liter/kg) CL2 (liter/kg/h) AUC (ng/ml h) Cmax (ng/ml) tα1/2 (h) tβ1/2 (h)
1 Compartment 0.832 0.834 0.17 0.149 63,705 48,317
0.669 0.588 0.127 0.11 56,589 35,854
1.179 1.037 0.2 0.198 92,939 57,596
2 Compartmentb 0.939 0.127 0.119 0.09 0.174 79,489 49,271 0.165 1.428
0.613 0.06 0.085 0.052 0.053 67,307 36,624 0.04 0.957
1.802 0.178 0.165 0.128 0.875 114,477 58,871 0.434 2.141
a

Median values are given in the top line of each row, and underneath are the range values. Regimen D, 600 mg zanamivir infused during 30 min. kel, elimination rate constant; t1/2, elimination half life (in a one-compartment model); V1, volume of the central (or only) compartment; CL, clearance from the central (or only) compartment; V2, volume of the second compartment; CL2, intercompartmental clearance; AUC, total area under the concentration-time curve; Cmax, maximum concentration; tα1/2, half life corresponding to the initial elimination phase (in a two-compartment model); tβ1/2, terminal elimination half life.

b

One subject was excluded, since the fit of the two-compartment model was poor.

HHS Vulnerability Disclosure